Whole Biome
2012
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series B
LATEST DEAL TYPE
$35M
LATEST DEAL AMOUNT
12
INVESTORS
Description
Provider of a microbiome diagnostics platform designed to improve healthcare services through microbiome interventions. The company's microbiome diagnostics platform integrates laboratory science and computational analysis to gain a comprehensive view of each individual's microbiome, enabling clinicians to identify specific microbiome markers and interventions to treat diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 933 20th Street
- San Francisco, CA 94107
- United States
+1 (415) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Whole Biome’s full profile, request a free trial.
Whole Biome Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Early Stage VC (Series B) | 30-May-2019 | $35M | 000.00 | 00000 | Completed | Startup |
| 7. Early Stage VC (Series A2) | 08-Jun-2017 | 000.00 | 000.00 | 0000 | Completed | Startup |
| 6. Early Stage VC (Series A) | 27-Jan-2016 | 000 | 000.00 | 0000 | Completed | Startup |
| 5. Grant | 01-Jan-2016 | 00000 | 00.00 | Completed | Startup | |
| 4. Seed Round | 15-Dec-2014 | 00.00 | 00.00 | 000.00 | Completed | Startup |
| 3. Accelerator/Incubator | 18-Jun-2014 | Completed | Startup | |||
| 2. Accelerator/Incubator | 13-Oct-2013 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Whole Biome Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series A | 11,797,144 | $0.000100 | $0.05 | $0.68 | $0.68 | 1x | $0.68 | 16.63% |
| Seed | 5,785,203 | $0.000100 | $0.05 | $0.64 | $0.64 | 1x | $0.64 | 8.16% |
Whole Biome Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Felicis Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Khosla Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SK Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| True Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |
Whole Biome Executive Team (7)
1 Former Executive
You’re viewing 5 of 7 executives. Get the full list »Whole Biome Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Adam D'Augelli | True Ventures | Board Member | 000 0000 | |
| Colleen Cutcliffe Ph.D | Whole Biome | Chief Executive Officer, Board Member & Co-Founder | 000 0000 | |
| Hugh Martin | Self | Board Member | 000 0000 | |
| John Eid Ph.D | Whole Biome | Chief Scientific Officer, Board Member & Co-Founder | 000 0000 | |
| Peter Hutt JD | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 7 board members. Get the full list »